These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31537335)

  • 1. A Strategy of Lead Abandonment in a Large Cohort of Patients With Sprint Fidelis Leads.
    Alqarawi W; Coppens J; Aldawood W; Ramirez FD; Redpath CJ; Nair GM; Nery PB; Davis DR; Abu Shama R; Aydin A; Klein A; Golian M; Schaller RD; Green MS; Birnie DH; Sadek MM
    JACC Clin Electrophysiol; 2019 Sep; 5(9):1059-1067. PubMed ID: 31537335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative outcomes of transvenous extraction of sprint fidelis and riata defibrillator leads: a single center experience.
    Richardson TD; Kolek MJ; Goyal SK; Shoemaker MB; Lewis AA; Rottman JN; Whalen SP; Ellis CR
    J Cardiovasc Electrophysiol; 2014 Jan; 25(1):36-42. PubMed ID: 24028661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biventricular defibrillator patients have higher complication rates after revision of recalled leads.
    Brumberg GE; Kaseer B; Shah H; Saba S; Jain S
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):665-71. PubMed ID: 22519559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead electrical parameters may not predict integrity of the Sprint Fidelis ICD lead.
    Maytin M; Epstein LM
    Heart Rhythm; 2012 Sep; 9(9):1446-51. PubMed ID: 22537883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.
    Brunner MP; Cronin EM; Jacob J; Duarte VE; Tarakji KG; Martin DO; Callahan T; Borek PP; Cantillon DJ; Niebauer MJ; Saliba WI; Kanj M; Wazni O; Baranowski B; Wilkoff BL
    Heart Rhythm; 2013 Oct; 10(10):1444-50. PubMed ID: 23816440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and long-term outcomes associated with recalled implantable cardioverter-defibrillator leads: A multicenter experience.
    Mar PL; John A; Kumar S; Barry N; Chen G; Longserre S; Kabra R; Atkins D; Koerber S; Hussein A; Bhakta D; Lakkireddy D; Gopinathannair R
    Heart Rhythm; 2020 Nov; 17(11):1909-1916. PubMed ID: 32512178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative outcomes of Riata and Fidelis lead management strategies: Results from the NCDR-ICD Registry.
    Zeitler EP; Wang Y; Pokorney SD; Curtis J; Prutkin JM
    Pacing Clin Electrophysiol; 2021 Nov; 44(11):1897-1906. PubMed ID: 34520564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generator exchange is associated with an increased rate of Sprint Fidelis lead failure.
    Lovelock JD; Patel A; Mengistu A; Hoskins M; El-Chami M; Lloyd MS; Leon A; DeLurgio D; Langberg JJ
    Heart Rhythm; 2012 Oct; 9(10):1615-8. PubMed ID: 22683747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost-effectiveness analysis of a proactive management strategy for the Sprint Fidelis recall: a probabilistic decision analysis model.
    Bashir J; Cowan S; Raymakers A; Yamashita M; Danter M; Krahn A; Lynd LD
    Heart Rhythm; 2013 Dec; 10(12):1761-7. PubMed ID: 24076445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lead integrity alert algorithm decreases inappropriate shocks in patients who have Sprint Fidelis pace-sense conductor fractures.
    Kallinen LM; Hauser RG; Tang C; Melby DP; Almquist AK; Katsiyiannis WT; Gornick CC
    Heart Rhythm; 2010 Aug; 7(8):1048-55. PubMed ID: 20493965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure.
    Hauser RG; Hayes DL
    Heart Rhythm; 2009 May; 6(5):605-10. PubMed ID: 19285920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome of implantable cardioverter defibrillators with recalled and non-recalled leads in Japanese patients. Increased failure rate of the Sprint Fidelis lead.
    Yanagisawa S; Inden Y; Shimano M; Yoshida N; Ichiyanagi H; Fujita M; Ohguchi S; Ishikawa S; Kato H; Okumura S; Miyoshi A; Nagao T; Yamamoto T; Hirai M; Murohara T
    Circ J; 2014; 78(2):353-9. PubMed ID: 24270680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age.
    Girerd N; Nonin E; Pinot J; Morel E; Flys C; Scridon A; Chevalier P
    Arch Cardiovasc Dis; 2011; 104(6-7):388-95. PubMed ID: 21798471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single-centre experience concerning the safety of Sprint Fidelis defibrillator lead extraction at the time of pulse generator replacement or in case of evidence of lead failure.
    Da Costa A; Da Cruz C; Romeyer-Bouchard C; Abdellaoui L; Nadrouss A; Bisch L; Chometon F; Afif Z; Gate-Martinet A; Combier M; Isaaz K
    Arch Cardiovasc Dis; 2012 Apr; 105(4):203-10. PubMed ID: 22633294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sprint Fidelis implantable cardioverter-defibrillators lead patient management and survival: Single center study.
    Grabowski M; Rokicki JK; Gajda S; Januszkiewicz Ł; Cacko A; Stolarz P; Opolski G
    Cardiol J; 2017; 24(3):259-265. PubMed ID: 27910085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Sprint Fidelis and Riata lead extraction: Data from 2 high-volume centers.
    El-Chami MF; Merchant FM; Levy M; Alam MB; Rattan R; Hoskins MH; Langberg JJ; Delurgio D; Lloyd MS; Leon AR; Saba S
    Heart Rhythm; 2015 Jun; 12(6):1216-20. PubMed ID: 25998138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator.
    Danik SB; Mansour M; Singh J; Reddy VY; Ellinor PT; Milan D; Heist EK; d'Avila A; Ruskin JN; Mela T
    Heart Rhythm; 2007 Apr; 4(4):439-42. PubMed ID: 17399630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of implanted recalled sprint Fidelis lead on patient mortality.
    Morrison TB; Friedman PA; Kallinen LM; Hodge DO; Crusan D; Kumar K; Hayes DL; Rea RF; Hauser RG
    J Am Coll Cardiol; 2011 Jul; 58(3):278-83. PubMed ID: 21737019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medtronic Sprint Fidelis lead recall: determining the initial 5-year management cost to Medicare.
    Mehrotra AK; Knight BP; Smelley MP; Shah DP; Weisberg I; Baez-Escudero J; Beshai JF; Burke MC
    Heart Rhythm; 2011 Aug; 8(8):1192-7. PubMed ID: 21377552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Sprint Fidelis and Riata defibrillator lead failure rates.
    Fazal IA; Shepherd EJ; Tynan M; Plummer CJ; McComb JM
    Int J Cardiol; 2013 Sep; 168(2):848-52. PubMed ID: 23138013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.